| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/18/2007 | CN100998871A Chiral medicine D-antothenic acid intercalation hydrotalcite and its preparation method |
| 07/18/2007 | CN100998865A Modicine and food dual-purpose composition using forest frog active peptide component as active constituent and its use |
| 07/18/2007 | CN100998861A Cerebroprotein hydrolysate sodium chloride injection |
| 07/18/2007 | CN100998844A Medicinal formula of compound effective site group of huomai-tiaozhi capsule and its preparation technology |
| 07/18/2007 | CN100998796A Health-care food for auxiliary treating high blood fat disease and its production method |
| 07/18/2007 | CN100998758A Medicine for treating diabetes and its preparing method |
| 07/18/2007 | CN100998739A Traditional Chinese medicine composition for reducing weight and beauty |
| 07/18/2007 | CN100998703A Medicine used for reducing weight, regulating fat metabolism and reducing blood fat |
| 07/18/2007 | CN100998683A Process for preparing granule of radix rehmanniae and radix achyranthis bidentatae |
| 07/18/2007 | CN100998674A Traditional Chinese medicine composition with functions of lowering blood-fat and reducing weight |
| 07/18/2007 | CN100998667A Medicine composition for lowering blood-fat |
| 07/18/2007 | CN100998650A Use of cinnamonum cassia for treating diabetes, its products and preparing method |
| 07/18/2007 | CN100998626A Method for preparing extract of korea thistle leaf |
| 07/18/2007 | CN100998623A New medicinal use of eupatorium lindleyanun |
| 07/18/2007 | CN100998607A Injecta containing compound bone peptide and sodium chloride |
| 07/18/2007 | CN100998603A Liquid vitamic C compounded nanometer elementary selenium its preparation method and storage method |
| 07/18/2007 | CN100998601A Medicine for treating diabete type-2 and its estimation model |
| 07/18/2007 | CN100998587A Application of 5-hydroxy furfurol for preparing medicine |
| 07/18/2007 | CN100998429A Superfine peanut powder rich in biological active component and its processing method |
| 07/18/2007 | CN100998426A Method for improving quality of fish meat by adding chitin |
| 07/18/2007 | CN100998418A Method for producing simulatives of maize proteolipin |
| 07/18/2007 | CN100998414A Application of powder of whole cannabis sativa seeds for preparing function food with adjuvant therapy of lowering blood fat |
| 07/18/2007 | CN100998413A Application of edestin for preparing functional food with adjuvant therapy of lowering blood fat |
| 07/18/2007 | CN100998411A Health-care food with anti-oxidation and lowering weight functions |
| 07/18/2007 | CN100998409A Raw material for making health-care food with functions of tonifying, refreshing and lowering user's weight and its product |
| 07/18/2007 | CN100998403A Composite nutrition nourishing containing Chinese wolfberry |
| 07/18/2007 | CN100998402A Flour made of broom corn millet and its production method |
| 07/18/2007 | CN100998401A Protein nutrition flour containing Chinese date, soybean and rice, and its processing method |
| 07/18/2007 | CN100998378A Bait used specially for atlantic trout |
| 07/18/2007 | CN100998377A Quick-frozen fresh forage used for special aquatic product and production process therefor |
| 07/18/2007 | CN100998371A Feed additive containing the fruit of Chinese wolfberry |
| 07/18/2007 | CN100998313A Production method of ginseng culture root extraction with high content of ginsenoside and its use |
| 07/17/2007 | USRE39734 Selenium source, a glutathione precursor of glutamic acid, cystine and glycine; increasing the content of glutathione in body tissue above that of a pretreatment level, enhancing immune activity |
| 07/17/2007 | US7244861 Insulin sensitizer; antidiabetic agents; antiproliferative agents; antiinflammatory agents |
| 07/17/2007 | US7244849 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease |
| 07/17/2007 | US7244848 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes |
| 07/17/2007 | US7244846 Substituted benzofuran-2-carboxamides derivatives |
| 07/17/2007 | US7244844 Reference standard for characterization of rosuvastatin |
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244749 Mixture of ascorbic acid, niacin, lysine and proline |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244727 Fused bicyclic nitrogen-containing heterocycles |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2321369C Dosing regimens for lasofoxifene |
| 07/17/2007 | CA2187186C Stable aqueous folinate solution |
| 07/14/2007 | WO2007067613A1 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase) |
| 07/12/2007 | WO2007079239A2 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof |
| 07/12/2007 | WO2007077995A1 Muscle-building agent |
| 07/12/2007 | WO2007077929A1 Therapeutic agent for metabolic syndrome and food containing the therapeutic agent |
| 07/12/2007 | WO2007077818A1 Asymmetric reduction method |
| 07/12/2007 | WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 07/12/2007 | WO2007077445A1 Method of diagnosis of a predisposition to laminitis |
| 07/12/2007 | WO2007077313A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 07/12/2007 | WO2007047725A3 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 07/12/2007 | WO2007046868A3 Thiazolidine derivatives and their uses as therapeutic agents |
| 07/12/2007 | WO2007044723A3 Methods for achieving and maintaining weight loss |
| 07/12/2007 | WO2007044318A3 Anti-hypercholesterolemic compounds |
| 07/12/2007 | WO2007031830A3 An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia |
| 07/12/2007 | WO2007022518A3 New uses of glucoregulatory proteins |
| 07/12/2007 | WO2007017240A3 Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids |
| 07/12/2007 | WO2006074957A9 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/12/2007 | US20070161787 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 07/12/2007 | US20070161708 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 07/12/2007 | US20070161702 Abca1 stabilizer |
| 07/12/2007 | US20070161689 Indoles having anti-diabetic activity |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161631 Substituted Phenoxyacetic Acids |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161602 Phosphonate compounds |
| 07/12/2007 | US20070161568 Use of GLP-1 peptides |
| 07/12/2007 | US20070161557 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
| 07/12/2007 | US20070160698 Muscular strength enhancing agent |
| 07/12/2007 | US20070160687 Composition for prevention and treatment of diabetic complication |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2636278A1 A dietary fibre comprising water-soluble .beta.-glucan and use thereof for treating or preventing metabolic syndrome |
| 07/12/2007 | CA2634320A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 07/12/2007 | CA2634074A1 Asymmetric reduction method |
| 07/12/2007 | CA2633167A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 07/12/2007 | CA2571156A1 Electrolyte supplement and method of use |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806347A1 Aromatic-ring-fused pyrimidine derivative |
| 07/11/2007 | EP1806341A2 (+)Phenyl-(4-{4-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-phenyl}-piperidin-1-yl)-acetic acid methyl ester as lipid lowering agent |
| 07/11/2007 | EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 07/11/2007 | EP1806140A1 Therapeutic or preventive agent for diabetic neuropathy |
| 07/11/2007 | EP1806133A1 Method for modifying the ambience, and spray liquid and sprayer used in the method |
| 07/11/2007 | EP1805159A1 Substituted carboxylic acids |
| 07/11/2007 | EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 07/11/2007 | EP1805156A2 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |